About CND Life Sciences
CND Life Sciences is a private company based in Scottsdale, Arizona. It has reported $30,003,983 raised in seven offerings on Form D since January 2021. Its chief executive is Richard Morello.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 16, 2026amended Aug 3, 2026 | $6,316,514fully sold | 14 | $451K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 28, 2025 | Mar 6, 2025amended May 6, 2025 | $8,648,469of $9.0M target | 38 | $227K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Mar 20, 2024 | Mar 27, 2024 | $2,007,000of $6.0M target | 22 | $91,227 | EquityRule 506(b) | Form D ↗ |
| Jul 14, 2023 | Jul 24, 2023 | $1,457,000fully sold | 19 | $76,684 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 16, 2022 | Sep 22, 2022amended Mar 24, 2023 | $4,500,000fully sold | 26 | $173K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 29, 2021 | Nov 10, 2021 | $4,200,000of $5.0M target | 22 | $190K | EquityRule 506(b) | Form D ↗ |
| Jan 5, 2021 | Jan 20, 2021amended Apr 28, 2021 | $2,875,000fully sold | 20 | $143K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, seven offerings | $30,003,983 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CND Life Sciences's Form D filed Aug 3, 2026.
Earlier filings also listed Roy Freeman (director, last listed Nov 2021).
Sources
- SECCND Life Sciences, Inc. Form D, filed Jun 16, 2026
- SECCND Life Sciences, Inc. Form D/A, filed Apr 15, 2025
- SECCND Life Sciences, Inc. Form D, filed Mar 6, 2025
- SECCND Life Sciences, Inc. Form D, filed Sep 22, 2022
- SECCND Life Sciences, Inc. Form D, filed Jan 20, 2021
- SECCND Life Sciences, Inc. filing history
- CompanyAbout CND Life Sciences
- PressCND Life Sciences FDA designation announcement